Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

Published September 5, 2024 | Version v1
Dataset Open

Genomic data from a pharmacogenetic study based on the efficacy of Tocilizumab in severe COVID-19 patients

Creators

Description

These data correspond to a pharmacogenetic study aimed to explore genetic associations related to the efficacy of Tocilizumab in severe COVID-19 patients. The study comprised two sets of patients, an initial subset consisted of 425 patients to whom a in-dpeth sequencing of a thermofisher sequencing panel of immune-related genes was performed, as well as a second set of 245 patients with the information of the genotyping of three selected SNPs

Files

gVCFs.zip

Files (172.7 MB)

Name Size Download all
md5:9087e0ff17c8c2732caebda20b923a0a
16.5 kB Download
md5:655127b0df25a6038fd4ae472f11d829
172.7 MB Preview Download
md5:20f24d880a6996e407fc9ed2d2d4772c
30.3 kB Download
md5:355df0f75014321f40c7af0d67eb7109
1.0 kB Preview Download

Additional details

Funding

axudas para o rescate de proxectos de investigación galegos presentados á convocatoria de expresións de interese do ISCIII para o financiamento de proxectos de investigación sobre o SARSCoV- 2 e a enfermidade COVID-19 con cargo ao Fondo COVID-19, susceptible de financiamento Feder no marco do programa operativo Feder Galicia 2014-2020 IN845D 2020/01
Xunta de Galicia